We are live on
!
Find out more
AC
Axon Capital Portfolio holdings
AUM
$69.3M
This Fund
S&P 500
This Quarter
Est. Return
+0.06%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$471M
AUM Growth
-$222M
(-32%)
Cap. Flow
-$219M
Cap. Flow
% of AUM
-46.58%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
12
New
1
Increased
2
Reduced
3
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$34.1M |
| 2 |
Sabre
SABR
|
+$17.7M |
| 3 |
ADPT
Adeptus Health Inc
ADPT
|
+$2.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GNC
GNC Holdings, Inc.
GNC
|
+$74.3M |
| 2 |
Amazon
AMZN
|
+$41.2M |
| 3 |
MON
Monsanto Co
MON
|
+$40M |
| 4 |
Tyson Foods
TSN
|
+$31.7M |
| 5 |
DOOR
MASONITE INTERNATIONAL CORP
DOOR
|
+$24.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 61.48% |
| 2 | Communication Services | 27.42% |
| 3 | Consumer Staples | 7.32% |
| 4 | Technology | 3.78% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
1
DELISTED
Allergan plc
AGN
| $204M | 43.22% |
884,496
+139,383
| +19% | +$34.1M |
|
|
TSG
2
DELISTED
The Stars Group Inc.
TSG
| $129M | 27.42% |
7,981,426
-15,370
| -0.2% | -$239K |
|
|
ADPT
3
DELISTED
Adeptus Health Inc
ADPT
| $65.9M | 13.98% |
1,530,863
+62,780
| +4% | +$2.83M |
|
|
4
Tyson Foods
TSN
$20.1B
| $34.5M | 7.32% |
461,732
-431,922
| -48% | -$31.7M |
|
5
HCA Healthcare
HCA
$82.8B
| $20.2M | 4.28% |
266,439
-272,207
| -51% | -$20.8M |
|
|
6
Sabre
SABR
$684M
| $17.8M | 3.78% |
+632,741
| New | +$17.7M |
|
|
7
Amazon
AMZN
$2.66T
| – | – |
-1,152,120
| Closed | -$41.2M |
|
8
Alphabet (Google) Class C
GOOG
$4.22T
| – | – |
-597,620
| Closed | -$20.7M |
|
|
9
Alphabet (Google) Class A
GOOGL
$4.24T
| – | – |
-588,680
| Closed | -$20.7M |
|
|
DOOR
10
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| – | – |
-368,420
| Closed | -$24.4M |
|
|
GNC
11
DELISTED
GNC Holdings, Inc.
GNC
| – | – |
-3,057,877
| Closed | -$74.3M |
|
|
MON
12
DELISTED
Monsanto Co
MON
| – | – |
-387,225
| Closed | -$40M |
|
Similar funds
YEPX
WG
FWA
VIM
CCM
FCI
RL
SCH
Axon Capital's Q3 2016 Portfolio in Review
As of Q3 2016, Axon Capital held 12 positions worth $471M, down 32% from $693M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Axon Capital withdrew a net $219M in Q3 2016, closing 6 positions and reducing 3 holdings. Its most notable exit was GNC Holdings, Inc., an estimated $74.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 61% of assets, up from 42% a quarter earlier, followed by Communication Services and Consumer Staples.
Against the trend, Axon Capital opened a new position in Sabre worth $17.8M.
- Axon Capital's largest Q3 2016 buy was Sabre: 632,741 shares worth $17.8M.
- Axon Capital added most to Allergan plc in Q3 2016, an estimated $34.1M increase.
- Axon Capital's biggest Q3 2016 reduction was Tyson Foods, cutting an estimated $31.7M.
- Axon Capital fully exited GNC Holdings, Inc. in Q3 2016, selling an estimated $74.3M.
- Axon Capital's ten largest holdings make up 100% of its $471M portfolio in Q3 2016.
- Axon Capital opened 1 new position and closed 6 in Q3 2016.
- Axon Capital's portfolio value fell 32% quarter-over-quarter to $471M.
Based on Axon Capital's 13F filing for Q3 2016, filed 14 Nov 2016.